Anteris Technologies Global Corp. Share Price
NASDAQ: AVR | Small CapAnteris Technologies Global Corp. Stock Performance
Open $8.49 | Prev. Close $8.37 | Circuit Range N/A |
Day Range $8.49 - $8.89 | Year Range $3.30 - $11.02 | Volume 24,360 |
Average Traded $8.76 |
Anteris Technologies Global Corp. Share Price Today
As of 10 August 2026, Anteris Technologies Global Corp.'s share price is $8.92. The stock opened at $8.49, compared to its previous close of $8.37. During today's trading session, Anteris Technologies Global Corp.'s share price traded between $8.49 and $8.89, with an average price of $8.69. Over the past 52 weeks, the stock has recorded a high of $11.02 and a low of $3.30. In terms of performance, Anteris Technologies Global Corp.'s share price has risen by 36.81% over the last six months and is up 123.56% on a year-on-year basis.
Anteris Technologies Global Corp. Share Price Chart
Anteris Technologies Global Corp. Stock Fundamentals & Key Indicators
Market Cap $329.60M | PE Ratio (TTM) -3.50 | Dividend Yield N/A |
EPS (TTM) $-2.55 | Revenue (TTM) $1.91M | Return On Equity (TTM) 101317.20% |
Profit Margin -4925.51% | Debt to Equity -229.82 | Quarterly Earnings Growth YoY N/A |
Anteris Technologies Global Corp. Quarterly Profit & Loss
All figures in USD
About Anteris Technologies Global Corp.
Anteris Technologies Global Corp., a structural heart company, develops and commercializes minimally invasive medical devices to treat heart valve diseases. It offers the DurAVR transcatheter heart valve system, a novel transcatheter aortic valve for the treatment of aortic stenosis that is shaped to mimic the performance of a healthy human aortic valve. The company also develops ADAPT anti-calcification tissue, an anti-calcification preparation that transforms xenograft tissue into durable bioscaffolds that are used to mimic human tissue for surgical repair in multiple settings, including aortic valve replacement; and ComASUR delivery system, a physician-developed balloon expandable delivery system that contains a reinforced steerable catheter for a precise deflection through the heart anatomy in a controlled manner to avoid damage to the aorta. Anteris Technologies Global Corp. is based in Toowong, Australia.
Anteris Technologies Global Corp. Historical Returns
| Month | Open | Close | Change % |
|---|---|---|---|
Aug 2026 | $8.01 | $8.92 | +13.49% |
Jul 2026 | $9.78 | $7.86 | -20.16% |
Jun 2026 | $8.54 | $9.85 | +14.34% |
May 2026 | $6.05 | $8.61 | +39.89% |
Apr 2026 | $5.79 | $6.16 | +10.90% |
Mar 2026 | $6.32 | $5.55 | -14.88% |
Feb 2026 | $5.96 | $6.52 | +9.40% |
Jan 2026 | $4.86 | $5.96 | +19.68% |
Dec 2025 | $3.96 | $4.98 | +21.02% |
Nov 2025 | $4.25 | $4.12 | -8.35% |
Oct 2025 | $4.30 | $4.49 | -0.22% |
Sep 2025 | $4.04 | $4.50 | +12.78% |